skip to content

Media

Access a wide range of materials relating to our company, our people, innovation, solutions and diagnostics tools or get in touch with us.

In the spotlight

Roche unveils its first ever Customer Experience Center in Chennai

Roche Pharma India today inaugurated an industry-first customer experience center; envisioned as a space to spur collaboration with healthcare professionals, researchers and educational institutions in an effor

Roche inaugurated a state-of-the-art Offshore Development Center (ODC)

This dedicated Roche ZS Associates ODC named YODAc (Your One stop shop for Data & Analytics Center) brings together many capabilities such as business data operations, data quality management, global analytical

Mr. André Hoffmann and Dr. Jörg Duschmalé in conversation with Fortune India magazine!

SWISS MULTINATIONAL healthcare company F. Hoffmann-La Roche AG, known as Roche, is one of the oldest privately held family businesses with a 125-year history. Experts say once a family business achieves scale, it should be entrusted to professionals.

Media Releases

Roche Launches Ocrevus® (Ocrelizumab) -a Breakthrough Blockbuster Therapy, Redefining Multiple Sclerosis (MS) Treatment in India

PDF

Roche launches Vabysmo® (faricimab), the first and only bispecific monoclonal antibody for the eye, to treat two leading causes of vision loss

PDF

Roche unveils its first ever Customer Experience Center in Chennai

PDF

Roche and ZS partner to set up dedicated center in Chennai

PDF

Roche Pharma India Launches Patient Support App To Help Patients Seamlessly Navigate Their Care Journey

PDF

Roche expands its Global Analytics and Technology Center of Excellence

PDF

Fighting HER2 + Breast Cancer with innovation and hope

PDF

View all releases

Roche in the news

View all

Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.

PDF

Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India

PDF

Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19

PDF

Media Enquiries

For media enquiries, please contact:

©  Roche Products (India) Pvt. Ltd.  

Disclaimer: The images on this website are for representation purpose only and do not indicate actual patient outcomes or the effects of any product.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us atOR please call the Roche India Safety Unit onor E-mail us at